Bioqual, Inc. (BIOQ) Financials
BIOQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Aug. 31, 2022 | ? | ? |
| May 31, 2022 | ? | ? |
| Feb. 28, 2022 | ? | ? |
| Nov. 30, 2021 | ? | ? |
BIOQ Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Aug. 31, 2022 | ? | ? |
| May 31, 2022 | ? | ? |
| Feb. 28, 2022 | ? | ? |
| Nov. 30, 2021 | ? | ? |
BIOQ Net Income
| Date | Net Income |
|---|---|
| Aug. 31, 2022 | 1.4 million |
| May 31, 2022 | 1.9 million |
| Feb. 28, 2022 | 856588 |
| Nov. 30, 2021 | 1.1 million |
BIOQ Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Aug. 31, 2022 | - | - | - |
| May 31, 2022 | - | - | - |
| Feb. 28, 2022 | - | - | - |
| Nov. 30, 2021 | - | - | - |
BIOQ Shares Outstanding
BIOQ Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Aug. 31, 2022 | 616223 | - | - | - |
| May 31, 2022 | 704210 | - | - | - |
| Feb. 28, 2022 | 736865 | - | - | - |
| Nov. 30, 2021 | 1.8 million | - | - | - |
BIOQ Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Aug. 31, 2022 | - | - |
| May 31, 2022 | - | - |
| Feb. 28, 2022 | - | - |
| Nov. 30, 2021 | - | - |
BIOQ
Price: $64
Dividend Yield: 0.78%
Forward Dividend Yield: 0.78%
Payout Ratio: 11.26%
Dividend Per Share: 0.50 USD
Earnings Per Share: 4.44 USD
P/E Ratio: 10.41
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 51
Ebitda: 7.2 millionMarket Capitalization: 57.3 million
Average Dividend Frequency: 1
Years Paying Dividends: 10
DGR3: 16.93%
DGR5: 13.49%